Wu, J., Kong, M., Lou, Y., Li, L., Yang, C., Xu, H., et al
Food and Drug Administration (FDA) announced that theyve cleared the first generic GLP-1 injectable to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes as an adjunct to diet and exercise. This language likely means that the drug will be available only to diabetics, in contrast to some of the name-brand medications in this class which have been approved for some weight loss cases
44.West S, Scragg J, Aveyard P, et al
Treatments Resources Who We Are Work With Us Treatments Resources Who We Are Work With Us Treatments Resources Who We Are Work With Us Treatments Resources Who We Are Work With Us Explore treatments designed around you Provider-guided care across weight loss, hair, skin, hormones, and mental health designed to feel more personal, accessible, and sustainable